Company: HURA
Filing Date: 2025-11-03
Form Type: S-3
Source: 0001193125-25-262843
Chunk: 29

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-11-03
Form: S-3
Chunk 29
---
 and information relating to such warrants, including, where applicable:

| • |     | the designation, aggregate principal amount, currencies, denominations and terms of the series of debt securities                                  
 purchasable upon exercise of warrants to purchase debt securities and the price at which such debt securities may be purchased upon such exercise; |

| • |     | the number of shares of common stock purchasable upon the exercise of warrants to purchase common stock and the 
 price at which such number of shares of common stock may be purchased upon such exercise;                       |

| • |     | the designation and number of units of other securities purchasable upon the exercise of warrants to purchase              
 other securities and the price at which such number of units of such other securities may be purchased upon such exercise; |

| • |     | the date on which the right to exercise such warrants shall commence and the date on which such right shall 
 expire;                                                                                                     |

| • |     | U.S. federal income tax consequences applicable to such warrants; |

| • |     | the amount of warrants outstanding as of the most recent practicable date; and |

| • |     | any other terms of such warrants. |

The exercise price for warrants will be subject to adjustment in accordance with the applicable prospectus supplement and/or other offering material. Each warrant will entitle the holder thereof to purchase such principal amount of debt securities or such number of shares of common stock or other securities at such exercise price as shall in each case be set forth in, or calculable from, the prospectus supplement and/or other offering material relating to the warrants, which exercise price may be subject to adjustment upon the occurrence of certain events as set forth in such prospectus supplement and/or other offering material. After the close of business on the expiration date, or such later date to which such expiration date may be extended by us, unexercised warrants will become void. The place or places where, and the manner in which, warrants may be exercised shall be specified in the prospectus supplement and/or other offering material relating to such warrants. Prior to the exercise of any warrants to purchase debt securities, common stock or other securities, holders of such warrants will not have any of the rights of holders of debt securities, common stock or other securities, as the case may be, purchasable upon such exercise of the warrants, including the right to receive payments of principal of, premium, if any, or interest, if any, on the debt securities purchasable upon such exercise or to